Washout Period When Starting Linezolid in Patients on Bupropion
A minimum washout period of 14 days is required when starting linezolid in patients who have been on bupropion due to the risk of serious drug interactions. 1
Mechanism of Interaction and Risks
- Linezolid is a reversible monoamine oxidase inhibitor (MAOI) that can interact with bupropion, potentially causing hypertensive reactions and serotonin syndrome 1
- The FDA label for bupropion specifically states that at least 14 days should elapse between discontinuation of bupropion and initiation of therapy with an MAOI such as linezolid 1
- Linezolid inhibits monoamine oxidases A and B, which can lead to dangerous interactions with drugs like bupropion that affect monoamine neurotransmitters 2
Clinical Decision Algorithm
Planned treatment (non-urgent situations):
Urgent situations requiring immediate linezolid:
- If urgent treatment with linezolid is required and acceptable alternatives are not available:
Post-linezolid considerations:
Pharmacokinetic Considerations
- Bupropion has a biphasic elimination with an initial half-life of approximately 1.5 hours and a second phase half-life of approximately 14 hours 5
- Linezolid has an elimination half-life of 5-7 hours 2
- The 14-day washout period provides sufficient time for bupropion and its active metabolites to be eliminated from the body before introducing linezolid 1
Monitoring During Transition
- During the washout period, monitor patients for:
Important Caveats and Pitfalls
- Despite the theoretical risk, a recent case series found only one definitive and two possible cases of serotonin syndrome among 194 encounters where linezolid was used concomitantly with medications that affect serotonin 4
- However, this does not negate the need for the recommended washout period, as severe reactions can occur even if relatively rare 1
- Do not attempt to overlap these medications or shorten the washout period, as this increases the risk of potentially life-threatening reactions 1